DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Klement G, Baruchel S, Rak J. et al.
Continuous low-dose therapy with vinblastine and VEGF re- ceptor-2 antibody induces sustained tumor regression without overt toxicity.
J Clin Invest 2000;
105: R1-R8.
Access:
We do not assume any responsibility for the contents of the web pages of other providers.